Statements: GSK Advance Company Ltd

Canonical ID: NK-QfFkwcpTeaFHBpwC4e2GeA · Entity type: Company (reference)

PropertyValueLangSource datasetSource IDFirst seen
Organization:addressAhmed Khair Street, 11111 Khartoum, SUDANbe_fod_sanctionseu-fsf-eu-11097-27
Organization:addressEntityaddr-f50fc4c4b7795ef4bb918bb67a8a6b4e74e46178be_fod_sanctionseu-fsf-eu-11097-27
Organization:countrysdbe_fod_sanctionseu-fsf-eu-11097-27
Organization:id945bc15227070f4b552b7a18c6b043cdf6e2dfecbe_fod_sanctionsbe-fod-deec9d50409099c0bb7f4fffc74ed635088b80b3
Organization:idffeab28a2b6afb999be4c9d33210b0d52656b022be_fod_sanctionseu-fsf-eu-11097-27
Organization:modifiedAt2024-01-22be_fod_sanctionseu-fsf-eu-11097-27
Organization:nameGSK ADVANCE COMPANY LTDengbe_fod_sanctionseu-fsf-eu-11097-27
Organization:nameGSK ADVANCE COMPANY LTDbe_fod_sanctionsbe-fod-deec9d50409099c0bb7f4fffc74ed635088b80b3
Organization:notesType of entity: Limited Company. 60 % owned by Major Algoney Hamdan Dagalobe_fod_sanctionseu-fsf-eu-11097-27
Organization:notes(Date of UN designation: 2024-01-22)be_fod_sanctionsbe-fod-deec9d50409099c0bb7f4fffc74ed635088b80b3
Organization:programIdEU-SDNZbe_fod_sanctionseu-fsf-eu-11097-27
Organization:sourceUrl https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=OJ:L_202400384be_fod_sanctionsbe-fod-deec9d50409099c0bb7f4fffc74ed635088b80b3
Organization:topicssanctionbe_fod_sanctionseu-fsf-eu-11097-27
Organization:topicssanctionbe_fod_sanctionsbe-fod-deec9d50409099c0bb7f4fffc74ed635088b80b3
  • Previous
  • 1 - 14 of 14
  • Next